NP Bioinnovation A/S

CVR 41598263 · Public limited company (A/S) · Active · Very high risk

NP Bioinnovation A/S is a Public limited company (A/S), founded on , based in Søborg. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 11.5% over the next 12 months, which is 8.2 times the average for Danish companies. 4 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK -5.4m and a net result of DKK -5.5m. CEO: Christian Torben Hill-Madsen.

Bankruptcy risk for NP Bioinnovation A/S

11.5%
probability of bankruptcy within 12 months
Very high risk

8.2 × the average (1.41%) · higher risk than 97% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
CEO's previous bankruptcies2 · bankruptcy rate 16.6%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×

Reduces the risk

Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Auditor's statementAudit · bankruptcy rate 5.8%0.66×
Has a boardYes · bankruptcy rate 6.0%0.68×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
41598263
Status
Active
Company type
Public limited company (A/S)
Founded
(6 years)
Address
Vandtårnsvej 62A, 1. b
2860 Søborg
Municipality
Gladsaxe
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 400k
Auditor
CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityYes
Equity ratio-63.1%
Current ratio60%
Moves (last 2 years)2
CEO changes in total3
CEO's previous bankruptcies2
Other companies at the address119
Going-concern uncertaintyYes

Financials and key figures

Financial year202620252024
Gross profitDKK 4.9mDKK -32kDKK -59k
Net profitDKK -5.5mDKK -60kDKK -80k
EquityDKK -5.4mDKK 168kDKK 228k
Total assetsDKK 8.5mDKK 200kDKK 262k
CashDKK 45kDKK 0–
Short-term debtDKK 13.8mDKK 32k–
Avg. employees110–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Crowe.

Filed annual reports

Reporting periodPublishedDays after period end
1 Apr 2025 – 31 Mar 2026184 Late
1 Apr 2024 – 31 Mar 2025184 Late
1 Apr 2023 – 31 Mar 202437
12 Aug 2020 – 31 Dec 2021180

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOChristian Torben Hill-MadsenCurrent
CEOHans Martin Dam
CEOTom Glæsner Larsen
BoardHenrik RoufCurrent
BoardPeter Severin BachCurrent
BoardAllan Traugott WehnertCurrent
BoardChristian Torben Hill-Madsen
BoardTom Glæsner Larsen
BoardChristian Torben Hill-Madsen
BoardHenrik Keller
Owner (100%)Nordicus Partners CorporationCurrent
Owner (50%)KARMA ApS
Owner (50%)Glæsner Holding ApS
Owner (100%)GK PARTNERS ApS
Owner (10%)Henrik Rouf
Owner (67%)GK PARTNERS ApS
Owner (5%)BIO-CONVERT A/S
AuditorCROWE STATSAUTORISERET REVISIONSINTERESSENTSKABCurrent
AuditorBeierholm Godkendt Revisionspartnerselskab
FounderKARMA ApSCurrent
FounderGlæsner Holding ApSCurrent

The CEOs' other companies

Christian Torben Hill-Madsen – 14 other companies, of which 2 bankrupt

Hans Martin Dam – 8 other companies

Tom Glæsner Larsen – 54 other companies, of which 15 bankrupt

Address history (4 moves)

Vandtårnsvej 62A, 1. b, 2860 Søborg
Vandtårnsvej 62A, 1. e, 2860 Søborg
c/o Firm Management ApS, Dyrehavevej 3B, 2930 Klampenborg
c/o Firm Management ApS, Dyrehavevej 3, st., 2930 Klampenborg
c/o c/o Firm Management ApS, Mesterlodden 3B, 1., 2820 Gentofte

Former names

NP Bioinnovation A/S – now
NP Communications A/S –
Managementselskabet af 12.08.2020 A/S –
NORDICUS Partners A/S –
NORDICUS Partners ApS –
GK Consult ApS –
Glæsner & Dam ApS –

Other companies at the same address

Similar companies in Gladsaxe

Questions and answers about NP Bioinnovation A/S

Has NP Bioinnovation A/S gone bankrupt?

No, NP Bioinnovation A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of NP Bioinnovation A/S?

Our model estimates a bankruptcy risk of 11.5% over the next 12 months (very high risk), which is 8.2 times the average for Danish companies.

Who is the CEO of NP Bioinnovation A/S?

Christian Torben Hill-Madsen is the CEO of NP Bioinnovation A/S.

Who is the auditor of NP Bioinnovation A/S?

NP Bioinnovation A/S most recently used CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB.

When was NP Bioinnovation A/S founded?

NP Bioinnovation A/S was founded on 12 August 2020.

What is the equity of NP Bioinnovation A/S?

Equity was DKK -5.4m according to the annual report for the period ending 31 March 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.